Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Neurodevelopmental Conditions”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableNot Yet RecruitingNCT07075107
What this trial is testing

Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases

Who this might be right for
Rare Genetic Disease
Assistance Publique Hopitaux De Marseille 62
Not applicableActive Not RecruitingNCT04126005
What this trial is testing

Natural History Study of Patients With Canavan Disease (CANinform Study)

Who this might be right for
Canavan Disease
Aspa Therapeutics 70
Not applicableStudy completedNCT00004449
What this trial is testing

Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism

Who this might be right for
Autistic Disorder
University of California, Los Angeles 102
Testing effectiveness (Phase 2)Looking for participantsNCT04998396
What this trial is testing

AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)

Who this might be right for
Canavan Disease
Aspa Therapeutics 26
Testing effectiveness (Phase 2)Temporarily pausedNCT00004300
What this trial is testing

Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis

Who this might be right for
Stereotyped BehaviorMental Retardation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 40
Not applicableLooking for participantsNCT05528744
What this trial is testing

Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome

Who this might be right for
Genetic DiseaseChopra-Amiel-Gordon SyndromeCAGS+1 more
Boston Children's Hospital 60
Not applicableStudy completedNCT05643274
What this trial is testing

Use of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles

Who this might be right for
Genetic DiseaseNeurologic DisorderDevelopmental Delay Disorder+1 more
Nantes University Hospital 10
Early research (Phase 1)Study completedNCT06480968
What this trial is testing

CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

Who this might be right for
Fragile X Syndrome
Connecta Therapeutics, S.L. 76
Not applicableEnded earlyNCT03472807
What this trial is testing

EXOme Rare Cancers in Children (EXOCARE)

Who this might be right for
Predisposition, GeneticCancer ChildhoodDevelopment Delay
University Hospital, Angers 169
Not applicableUnknownNCT03424772
What this trial is testing

Whole Genome Sequencing in the Detection of Rare Undiagnosed Genetic Diseases in Children in China

Who this might be right for
Intellectual DisabilityMultiple Congenital AnomalyRare Diseases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableStudy completedNCT00004325
What this trial is testing

Study of the Neurobiology of Tourette Syndrome and Related Disorders

Who this might be right for
Tourette SyndromeObsessive Compulsive Disorder
National Center for Research Resources (NCRR) 200
Not applicableNot Yet RecruitingNCT07400913
What this trial is testing

Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases.

Who this might be right for
Rare DiseasesAlbinismIntellectual Disability
University Hospital, Bordeaux 150
Not applicableStudy completedNCT06612333
What this trial is testing

Evaluation of the French Version of the PEERS Social Skills Training Program for Adolescents With Rare Neurodevelopmental Disorders

Who this might be right for
Neurodevelopmental DisordersRare Diseases
Imagine Institute 64
Large-scale testing (Phase 3)Study completedNCT00004376
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder

Who this might be right for
Tourette Syndrome
National Center for Research Resources (NCRR) 35
Not applicableLooking for participantsNCT07329257
What this trial is testing

Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)

Who this might be right for
Baker Gordon SyndromeRare Neurodevelopmental ConditionsRare Neurogenetic Conditions+6 more
University of Missouri-Columbia 100
Testing effectiveness (Phase 2)Study completedNCT00004393
What this trial is testing

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Who this might be right for
Tourette Syndrome
National Center for Research Resources (NCRR) 50
Testing effectiveness (Phase 2)Study completedNCT00004652
What this trial is testing

Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

Who this might be right for
Tourette Syndrome
National Center for Research Resources (NCRR) 20
Not applicableStudy completedNCT06957054
What this trial is testing

Neural Biomarkers in Fragile X Syndrome

Who this might be right for
Fragile X Syndrome (FXS)Neurotypical Adults
Connecta Therapeutics, S.L. 20
Not applicableLooking for participantsNCT06399952
What this trial is testing

Baker Gordon Syndrome Natural History Study

Who this might be right for
Rare DiseasesAutism or Autistic TraitsDevelopment Delay+4 more
University of Missouri-Columbia 50
Not applicableLooking for participantsNCT01087320
What this trial is testing

Genome Medical Sequencing for Gene Discovery

Who this might be right for
Intellectual DisabilitiesCongenital AnomalyRare Disorders
National Human Genome Research Institute (NHGRI) 2,000
Load More Results